Urea transporter UT‐A1 as a novel drug target for hyponatremia

Abstract

Hyponatremia is the most common disorder of electrolyte imbalances. It is necessary to develop new type of diuretics to treat hyponatremia without losing electrolytes. Urea transporters (UT) play an important role in the urine concentrating process and have been proved as a novel diuretic target. In this study, rat and mouse syndromes of inappropriate antidiuretic hormone secretion (SIADH) models were constructed and analyzed to determine if UTs are a promising drug target for treating hyponatremia. Experimental results showed that 100 mg/kg UT inhibitor 25a significantly increased serum osmolality (from 249.83 ± 5.95 to 294.33 ± 3.90 mOsm/kg) and serum sodium (from 114 ± 2.07 to 136.67 ± 3.82 mmol/L) respectively in hyponatremia rats by diuresis. Serum chemical examination showed that 25a neither caused another electrolyte imbalance nor influenced the lipid metabolism. Using UT‐A1 and UT‐B knockout mouse SIADH model, it was found that serum osmolality and serum sodium were lowered much less in UT‐A1 knockout mice than in UT‐B knockout mice, which suggest UT‐A1 is a better therapeutic target than UT‐B to treat hyponatremia. This study provides a proof of concept that UT‐A1 is a diuretic target for SIADH‐induced hyponatremia and UT‐A1 inhibitors might be developed into new diuretics to treat hyponatremia.